To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
U2OS cells were cultured in McCoys 5A with 10% FCS (Gibco, Invitrogen) and 1% glutamax, 0.5 g/ml hydrocortisone
Spending 6 to 8 weeks at each dose instead of 4 gives the body more time to adapt while maintaining the pharmacokinetic profile that the clinical trials validated
Prevent glucose spikes with a tablet that increases insulin sensitivity and disposes of excess glucose in the liver, muscle, fat, and brain
While semaglutide is primarily used to treat type 2 diabetes, studies have shown that it may also have potential benefits for individuals with hypertension, regardless of whether they have diabetes or not